Literature DB >> 32976873

Radiotherapy Treatment plannINg study Guidelines (RATING): A framework for setting up and reporting on scientific treatment planning studies.

Christian Rønn Hansen1, Wouter Crijns2, Mohammad Hussein3, Linda Rossi4, Pedro Gallego5, Wilko Verbakel6, Jan Unkelbach7, David Thwaites8, Ben Heijmen4.   

Abstract

Radiotherapy treatment planning studies contribute significantly  to advances and improvements in radiation treatment of cancer patients. They are a pivotal step to support and facilitate the introduction of novel techniques into clinical practice, or as a first step before clinical trials can be carried out. There have been numerous examples published in the literature that demonstrated the feasibility of such techniques as IMRT, VMAT, IMPT, or that compared different treatment methods (e.g. non-coplanar vs coplanar treatment), or investigated planning approaches (e.g. automated planning). However, for a planning study to generate trustworthy new knowledge and give confidence in applying its findings, then its design, execution and reporting all need to meet high scientific standards. This paper provides a 'quality framework' of recommendations and guidelines that can contribute to the quality of planning studies and resulting publications. Throughout the text, questions are posed and, if applicable to a specific study and if met, they can be answered positively in the provided 'RATING' score sheet. A normalised weighted-sum score can then be calculated from the answers as a quality indicator. The score sheet can also be used to suggest how the quality might be improved, e.g. by focussing on questions with high weight, or by encouraging consideration of aspects given insufficient attention. Whilst the overall aim of this framework and scoring system is to improve the scientific quality of treatment planning studies and papers, it might also be used by reviewers and journal editors to help to evaluate scientific manuscripts reporting planning studies.
Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Guidelines; Plan comparison; Plan quality; Radiotherapy; Treatment planning

Mesh:

Year:  2020        PMID: 32976873     DOI: 10.1016/j.radonc.2020.09.033

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Organ-at-risk sparing with dynamic trajectory radiotherapy for head and neck cancer: comparison with volumetric arc therapy on a publicly available library of cases.

Authors:  Jenny Bertholet; Paul-Henry Mackeprang; Silvan Mueller; Gian Guyer; Hannes A Loebner; Yanick Wyss; Daniel Frei; Werner Volken; Olgun Elicin; Daniel M Aebersold; Michael K Fix; Peter Manser
Journal:  Radiat Oncol       Date:  2022-07-15       Impact factor: 4.309

2.  The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer.

Authors:  Lynsey Devlin; Laura Grocutt; Bianca Hunter; Hiwot Chemu; Aileen Duffton; Alec McDonald; Nicholas Macleod; Philip McLoone; Sean M O'Cathail
Journal:  Clin Transl Radiat Oncol       Date:  2022-06-11

3.  Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.

Authors:  Anita M Werensteijn-Honingh; Petra S Kroon; Dennis Winkel; J Carlijn van Gaal; Jochem Hes; Louk M W Snoeren; Jaleesa K Timmer; Christiaan C P Mout; Gijsbert H Bol; Alexis N Kotte; Wietse S C Eppinga; Martijn Intven; Bas W Raaymakers; Ina M Jürgenliemk-Schulz
Journal:  Phys Imaging Radiat Oncol       Date:  2022-06-30

Review 4.  Metrics to evaluate the performance of auto-segmentation for radiation treatment planning: A critical review.

Authors:  Michael V Sherer; Diana Lin; Sharif Elguindi; Simon Duke; Li-Tee Tan; Jon Cacicedo; Max Dahele; Erin F Gillespie
Journal:  Radiother Oncol       Date:  2021-05-11       Impact factor: 6.901

5.  Complementing Prostate SBRT VMAT With a Two-Beam Non-Coplanar IMRT Class Solution to Enhance Rectum and Bladder Sparing With Minimum Increase in Treatment Time.

Authors:  Abdul Wahab M Sharfo; Linda Rossi; Maarten L P Dirkx; Sebastiaan Breedveld; Shafak Aluwini; Ben J M Heijmen
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

6.  Treatment plan comparison of proton vs photon radiotherapy for lower-grade gliomas.

Authors:  Camilla S Byskov; Christian R Hansen; Rikke H Dahlrot; Lene Haldbo-Classen; Charlotte A Haslund; Flemming Kjær-Kristoffersen; Thomas O Kristensen; Yasmin Lassen-Ramshad; Slávka Lukacova; Aida Muhic; Petra W Nyström; Britta Weber; Jesper F Kallehauge
Journal:  Phys Imaging Radiat Oncol       Date:  2021-11-28

7.  MR-Linac Radiotherapy - The Beam Angle Selection Problem.

Authors:  Rik Bijman; Linda Rossi; Tomas Janssen; Peter de Ruiter; Baukelien van Triest; Sebastiaan Breedveld; Jan-Jakob Sonke; Ben Heijmen
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

8.  Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients.

Authors:  Frederik R Teunissen; Ruud C Wortel; Jochem Hes; Thomas Willigenburg; Eline N de Groot-van Breugel; Johannes C J de Boer; Harm H E van Melick; Helena M Verkooijen; Jochem R N van der Voort van Zyp
Journal:  Phys Imaging Radiat Oncol       Date:  2021-09-21

9.  Evaluation of two independent dose prediction methods to personalize the automated radiotherapy planning process for prostate cancer.

Authors:  Martijn Kusters; Kentaro Miki; Liza Bouwmans; Karl Bzdusek; Peter van Kollenburg; Robert Jan Smeenk; René Monshouwer; Yasushi Nagata
Journal:  Phys Imaging Radiat Oncol       Date:  2022-02-03

10.  Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose.

Authors:  L Wilke; C Moustakis; O Blanck; D Albers; C Albrecht; Y Avcu; R Boucenna; K Buchauer; T Etzelstorfer; C Henkenberens; D Jeller; K Jurianz; C Kornhuber; M Kretschmer; S Lotze; K Meier; P Pemler; A Riegler; A Röser; D Schmidhalter; K H Spruijt; G Surber; V Vallet; R Wiehle; J Willner; P Winkler; A Wittig; M Guckenberger; S Tanadini-Lang
Journal:  Strahlenther Onkol       Date:  2021-07-01       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.